COLESTID Izrael - engleski - Ministry of Health

colestid

pfizer pfe pharmaceuticals israel ltd - colestipol hydrochloride - granules - colestipol hydrochloride 5 g/sachet - adjunctive therapy to diet in the managnent of elevated cholesterol levels.

EUTHYROX TABLET 75 mcg Singapur - engleski - HSA (Health Sciences Authority)

euthyrox tablet 75 mcg

merck pte. ltd. - levothyroxine sodium - tablet - 75 mcg - levothyroxine sodium 75 mcg

EUTHYROX  TABLET 50 mcg Singapur - engleski - HSA (Health Sciences Authority)

euthyrox tablet 50 mcg

merck pte. ltd. - levothyroxine sodium - tablet - 50 mcg - levothyroxine sodium 50 mcg

EUTHYROX TABLET 100 mcg Singapur - engleski - HSA (Health Sciences Authority)

euthyrox tablet 100 mcg

merck pte. ltd. - levothyroxine sodium - tablet - 100 mcg - levothyroxine sodium 100 mcg

EUTHYROX TABLET 25 mcg Singapur - engleski - HSA (Health Sciences Authority)

euthyrox tablet 25 mcg

merck pte. ltd. - levothyroxine sodium - tablet - 25 mcg - levothyroxine sodium 25 mcg

Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau) Europska Unija - engleski - EMA (European Medicines Agency)

chenodeoxycholic acid leadiant (previously known as chenodeoxycholic acid sigma-tau)

leadiant gmbh - chenodeoxycholic acid - xanthomatosis, cerebrotendinous; metabolism, inborn errors - bile and liver therapy - chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.

CHENODEOXYCHOLIC ACID LEADIANT Izrael - engleski - Ministry of Health

chenodeoxycholic acid leadiant

mbi pharma ltd., israel - chenodeoxycholic acid - hard capsule - chenodeoxycholic acid 250 mg - chenodeoxycholic acid - the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.